MEDMIRA INC (MIR.CA) Stock Price, Forecast & Analysis
Canada - TSX Venture Exchange - TSX-V:MIR - CA58501R1029 - Common Stock
MIR.CA Key Statistics, Chart & Performance
The current stock price of MIR.CA is 0.07 CAD. In the past month the price increased by 7.69%. In the past year, price decreased by -46.15%.
MIR.CA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| PRN.CA | PROFOUND MEDICAL CORP | N/A | 353.52M | ||
| TLT.CA | THERALASE TECHNOLOGIES INC | N/A | 60.71M | ||
| PINK.CA | PERIMETER MEDICAL IMAGING AI | N/A | 38.98M | ||
| VPT.CA | VENTRIPOINT DIAGNOSTICS LTD | N/A | 22.64M | ||
| ASG.CA | AURORA SPINE CORP | N/A | 20.85M | ||
| NSCI.CA | NANALYSIS SCIENTIFIC CORP | N/A | 19.68M | ||
| MDX.CA | MEDX HEALTH CORP | N/A | 18.04M | ||
| THRM.CA | THERMA BRIGHT INC | N/A | 3.98M | ||
| VER-H.CA | VERISANTE TECHNOLOGY INC | N/A | 439.40K | ||
| CNVI.CA | CONAVI MEDICAL CORP | N/A | 34.54M | ||
| VVTM.CA | VVT MED INC | N/A | 22.72M |
Related stock screener links
About MIR.CA
Company Profile
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. The company provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
Company Info
MEDMIRA INC
155 Chain Lake Dr.,, Suite 1
Halifax NOVA SCOTIA B3S 1B3 CA
CEO: Hermes Chan
Employees: 0
Phone: 19024501588
MEDMIRA INC / MIR.CA FAQ
What does MIR do?
MedMira, Inc. is a biotechnology company, which engages in the development and commercialization of rapid diagnostics and technology platforms. The company is headquartered in Halifax, Nova Scotia. The firm's tests provide hospitals, labs, clinics and individuals with an instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The firm is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. The company provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.
Can you provide the latest stock price for MEDMIRA INC?
The current stock price of MIR.CA is 0.07 CAD. The price increased by 7.69% in the last trading session.
Does MEDMIRA INC pay dividends?
MIR.CA does not pay a dividend.
How is the ChartMill rating for MEDMIRA INC?
MIR.CA has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the sector and industry classification for MEDMIRA INC?
MEDMIRA INC (MIR.CA) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Can you provide the number of employees for MEDMIRA INC?
MEDMIRA INC (MIR.CA) currently has 0 employees.
What is the next earnings date for MIR stock?
MEDMIRA INC (MIR.CA) will report earnings on 2026-03-30.
MIR.CA Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to MIR.CA. When comparing the yearly performance of all stocks, MIR.CA is a bad performer in the overall market: 96.03% of all stocks are doing better.
MIR.CA Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to MIR.CA. Both the profitability and financial health of MIR.CA have multiple concerns.
MIR.CA Financial Highlights
Over the last trailing twelve months MIR.CA reported a non-GAAP Earnings per Share(EPS) of -0.01. The EPS decreased by -38.3% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -122.89% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |